GRI
USDGRI Bio Inc. Common Stock
$1.680-0.080 (-4.545%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.760
High
$1.760
Low
$1.600
Volume
0.06M
Company Fundamentals
Market Cap
4.2M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.17M
Exchange
NCM
Currency
USD
52-Week Range
Low $1.1Current $1.680High $16.949
Related News
Analyst Upgrades
Ascendiant Capital Maintains Buy on GRI Bio, Raises Price Target to $35
Ascendiant Capital analyst Edward Woo maintains GRI Bio with a Buy and raises the price target from $34 to $35.
View more
GlobeNewswire
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF")
No decline in lung function observed at 6-week interim analysis builds upon positive safety and biomarker data Phase 2a study fully enrolled; Topline data on track for Q3 2025 Currently available treatments for IPF are
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.